Sculptor Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$847M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$480M |
| 3 |
TC Energy
TRP
|
+$373M |
| 4 |
AGN
Allergan plc
AGN
|
+$370M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$340M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$304M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$280M |
| 3 |
Medtronic
MDT
|
+$223M |
| 4 |
T-Mobile US
TMUS
|
+$194M |
| 5 |
Ally Financial
ALLY
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 42.25% |
| 2 | Healthcare | 14.21% |
| 3 | Industrials | 7.92% |
| 4 | Materials | 5.75% |
| 5 | Consumer Discretionary | 5.55% |
Similar funds
Sculptor Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Sculptor Capital held 905 positions worth $34.6B, up 3.3% from $33.5B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Sculptor Capital deployed $2.07B of net new capital in Q3 2014, opening 143 new positions and adding to 157 existing holdings. Its largest new stake was COVIDIEN PLC COM SHS NEW (IRELAND): 5,422,079 shares worth $469M.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, down from 50% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Time Warner Inc, an estimated $280M trimmed.
- Sculptor Capital's largest Q3 2014 buy was COVIDIEN PLC COM SHS NEW (IRELAND): 5,422,079 shares worth $469M.
- Sculptor Capital added most to AbbVie in Q3 2014, an estimated $847M increase.
- Sculptor Capital's biggest Q3 2014 reduction was Time Warner Inc, cutting an estimated $280M.
- Sculptor Capital fully exited Viatris in Q3 2014, selling an estimated $304M.
- Sculptor Capital's ten largest holdings make up 19% of its $34.6B portfolio in Q3 2014.
- Sculptor Capital opened 143 new positions and closed 146 in Q3 2014.
- Sculptor Capital's portfolio value rose 3.3% quarter-over-quarter to $34.6B.
Based on Sculptor Capital's 13F filing for Q3 2014, filed 14 Nov 2014.